Similar Items: Development and evaluation of a bivalent Lumpy skin disease vaccine and vaccine vector
- An evaluation of the vaccine-vector potential of thymidine kinase-disrupted recombinants of lumpy skin disease virus (South African vaccine)
- Determination and analysis of the complete genome sequences of a vaccine strain and field isolate of Lumpy Skin Disease Virus (LSDV)
- Semen quality and the excretion of lumpy skin disease virus in semen following vaccination and experimental challenge of vaccinated bulls
- Evaluation of an authentic bi-directional promoter in a new transfer vector for generating LSDV recombinants
- Molecular characterization of important regions of the lumpy skin disease virus genome
- Characterisation of promoter sequences in a Capripoxvirus genome
Author: Theron, Jacques
- Characterization of genetic elements up-regulated in Pseudomonas aeruginosa PAO biofilms and transcriptional activity of the flagellar hook protein gene, flgE, during biofilm development
- Evaluation of thermally regulated promoter systems for use in Escherichia coli and Bacillus subtilis
- Expression of the botulinum neurotoxin serotype D binding domain in Brevibacillus brevis and its evaluation as a candidate vaccine antigen in mice
- Proteomic analysis of the biofilm and biofilm-associated phenotypes of Pseudomonas aeruginosa cultured in batch
- Identification of viral proteins and cellular pathways involved in the induction of apoptosis of African horse sickness virus-infected mammalian cells
- Importance of an arginine-glycine-aspartic acid (RGD) motif in the VP7 protein of African horse sickness virus to mediate insect cell binding